Horizon Quantum Books $33.4 Million Profit That Cash Did Not Touch

By Tom Whitfield

Horizon Quantum Holdings Ltd. (NASDAQ: HQ) reported third-quarter net income of $33.4 million, and $43.1 million of that result came from a non-cash accounting gain on warrants. Strip the gain out and the underlying business lost more money than a year ago. The quarter ended Sept. 30; the company disclosed the figures in a Nov. 10 press release filed as Exhibit 99.1 to a Form 6-K.

The profit headline deserves inspection before celebration. Per the release, the $33.4 million net income compares with a $5.2 million loss in the third quarter of 2025 — a swing of $38.6 million. Basic earnings per ordinary share were $0.61 against a loss of $0.13 a year earlier.

Where did the profit come from?

The gain arose from remeasuring warrant-related derivative liabilities. A lower share price during the quarter cut the fair value of those liabilities, and accounting rules book the reduction as income. The gain exceeds the entire reported profit. It did not touch cash.

The operating figures tell the plainer story. Operating loss widened to $10.5 million from $4.9 million, an increase of $5.6 million. The company booked no revenue in either third quarter. Adjusted EBITDA, which removes the derivative gain and share-based pay, showed a loss of $6.3 million against $3.0 million a year earlier.

The takeaway in plain words: every dollar of reported profit came from an accounting entry, while the operating business spent more than twice what it spent last year.

Which costs are climbing?

Two lines drove the deterioration, according to the release:

• Research and development spending rose 122% to $4.5 million from $2.0 million.
• General and administrative costs rose 127% to $5.2 million from $2.3 million.

The company attributes the increases mainly to the costs of becoming a public company and additional research and development staff. Both explanations are verifiable in future filings; neither, it should be noted, comes with a stated ceiling or a target date for narrowing.

What does the balance sheet show?

Cash and cash equivalents ended September at $102.8 million, down from $113.3 million at June 30 — a decline of $10.5 million in three months. Over nine months, operations consumed $16.4 million and equipment purchases took $11.0 million.

Financing more than covered that burn. The company brought in $130.1 million across the period: $98.2 million net of costs from the merger and PIPE transaction, and $28.7 million from warrant exercises. That inflow rebuilt the equity account. Stockholders' equity stood at $84.1 million at Sept. 30 against a deficit of $4.7 million at Dec. 31, 2025.

Total liabilities were $34.7 million, of which $32.4 million were warrant derivative liabilities. Those liabilities swing both ways. Changes in their fair value cost the company $62.2 million over the nine months, and the net loss for that period was $85.4 million.

The one-sentence read: financing fixed the equity column, but nine-month results still carry an $85.4 million net loss driven by the same derivative mechanics that produced the third-quarter gain.

Prior OptimistFi research had argued that Horizon Quantum's equity value depended on new financing or a restructuring because the company was balance-sheet insolvent. The filing weakens that premise — equity is back in positive territory. The caveat follows: the business does not yet pay its own way, and the release itself warns that remaining warrants are remeasured each quarter, so share-price moves could bring further non-cash gains or losses in either direction.

What did the company announce alongside the numbers?

Two operational developments accompanied the release:

• The company completed pulse-level integration of its Triple Alpha development environment with the 32-qubit Toshiko processor of Oxford Quantum Circuits (OQC).
• It signed a non-binding letter of intent to acquire Entropica Labs Pte. Ltd., a Singapore-based quantum software company focused on error correction and fault tolerance, for an anticipated $27 million in Horizon Quantum Class A ordinary shares.

The Entropica transaction remains a letter of intent, not a deal. It still requires due diligence, related audits, definitive agreements and other customary conditions. Signing would make the proposed share payment binding.

What comes next?

The next quarterly report will answer two questions: whether cash keeps falling from the September level of $102.8 million, and how warrant remeasurement moves reported earnings again.

Until the operating loss narrows, the profit line belongs to the share price, not to the business.